Log In
BCIQ
Print this Print this
 

Survival of motor neuron 2 centromeric (SMN2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Survival of motor neuron 2 centromeric (SMN2)

BCIQ
Print ChartPrint this
Phase III, 1 Phase I/II, 1 Phase I, 1 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase III
Neurology

1

1

1

1




 Products Targeting Survival of motor neuron 2 centromeric (SMN2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$789.0M

$30.0M

$730.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/09/2012

$299.0M

0

$270.0M

12/05/2011

$490.0M

$30.0M

$460.0M

Get a free BioCentury Trial today